Enterprise record
Alpha ID: alpha:company:057af736-c4ac-436d-949a-6201d256d122Version: public-1
34 published Claims7 sources
The enterprise, in context.
Connect capital, control, accountability, and evidence.
Governance priorities
Capital allocationInspect reported performance, cash generation, and investment.Board accountabilityWho holds each mandate, and what evidence supports it?Ownership & votingSeparate economic interests from voting authority.Key Claims
Board and committees
Financial statements
Published financial observations retain their reported values, periods, and sources. Coverage may be partial; this is not a reconstructed complete financial statement.
All financials coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageControl and shareholders
Control and shareholders coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageCompensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAuditors, advisors and reporting
Auditors, advisors and reporting coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageLegal
Legal coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAI governance
AI governance coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageEvidence, history and coverage
Additional published Claims
Published evidence records
7 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
Alpha canonical company public projection
canonical identity · Source published: Date unavailable · Retrieved: Oct 3, 2026
Supports 3 claims
- Legal Name: Compass Therapeutics, Inc. · Claim reviewed: Oct 3, 2026
- Entity Status: Public listing published · Claim reviewed: Oct 3, 2026
- Published Fact: US · Claim reviewed: Oct 3, 2026
SEC DEF 14A 0001140361-26-017649
sec def 14a · Source published: Apr 29, 2026 · Retrieved: Sep 6, 2026
Supports 14 claims
- Leadership Role: Carl L. Gordon, Ph.D., C.F.A.: Chairman of the Board · Claim reviewed: Oct 3, 2026
- Leadership Role: Ellen Chiniara, J.D.: Director · Claim reviewed: Oct 3, 2026
- Leadership Role: James P. Boylan, M.B.A.: Director · Claim reviewed: Oct 3, 2026
- Leadership Role: Mary Ann Gray, Ph.D.: Director · Claim reviewed: Oct 3, 2026
- Leadership Role: Philip J. Ferneau, M.B.A, J.D.: Director · Claim reviewed: Oct 3, 2026
- Leadership Role: Richard S. Lindahl, M.B.A.: Director · Claim reviewed: Oct 3, 2026
- Leadership Role: Thomas J. Schuetz, M.D., Ph.D.: Vice Chairman of the Board and Chief Executive Officer · Claim reviewed: Oct 3, 2026
- Leadership Role: Arjun Prasad, M.B.A., M.P.H.: Chief Commercial Officer · Claim reviewed: Oct 3, 2026
- Leadership Role: Barry Shin, J.D., M.B.A.: Chief Financial Officer · Claim reviewed: Oct 3, 2026
- Leadership Role: Bing Gong, Ph.D.: Chief Scientific Officer · Claim reviewed: Oct 3, 2026
- Leadership Role: Cynthia Sirard, M.D.: Chief Medical Officer · Claim reviewed: Oct 3, 2026
- Leadership Role: Jonathan E. Anderman, J.D.: General Counsel and Corporate Secretary · Claim reviewed: Oct 3, 2026
- Leadership Role: Neil Lerner, C.P.A.: Chief Accounting Officer · Claim reviewed: Oct 3, 2026
- Leadership Role: Thomas J. Schuetz, M.D., Ph.D.: Chief Executive Officer · Claim reviewed: Oct 3, 2026
DEF 14A edge20068103x1_def14a.htm
sec proxy · Source published: Apr 29, 2026 · Retrieved: Sep 2, 2026
Supports 6 claims
- Leadership Role: Ellen Chiniara: Director · Claim reviewed: Oct 3, 2026
- Leadership Role: James P. Boylan: Director · Claim reviewed: Oct 3, 2026
- Leadership Role: Jonathan E. Anderman: Director · Claim reviewed: Oct 3, 2026
- Leadership Role: Mary Ann Gray: Director · Claim reviewed: Oct 3, 2026
- Leadership Role: Richard S. Lindahl: Director · Claim reviewed: Oct 3, 2026
- Leadership Role: Thomas J. Schuetz: Director · Claim reviewed: Oct 3, 2026
CMPX 10-K executive officers
sec filing · Source published: Mar 5, 2026 · Retrieved: May 4, 2026
Supports 3 claims
- Leadership Role: Barry Shin: Chief Financial Officer · Claim reviewed: Oct 3, 2026
- Leadership Role: Neil Lerner: Chief Accounting Officer · Claim reviewed: Oct 3, 2026
- Leadership Role: Thomas J. Schuetz: Chief Executive Officer and Vice Chair of the Board · Claim reviewed: Oct 3, 2026
AUDIT COMMITTEE
sec proxy · Source published: Date unavailable · Retrieved: Date unavailable
Supports 3 claims
- Committee Record: AUDIT COMMITTEE: Chair Richard S. Lindahl; Members Richard S. Lindahl (Chair); Ellen Chiniara · Claim reviewed: Oct 3, 2026
- Committee Appointment: Richard S. Lindahl: chair, AUDIT COMMITTEE · Claim reviewed: Oct 3, 2026
- Committee Appointment: Ellen Chiniara: member, AUDIT COMMITTEE · Claim reviewed: Oct 3, 2026
Compensation Committee
sec proxy · Source published: Date unavailable · Retrieved: Date unavailable
Supports 3 claims
- Committee Record: Compensation Committee: Chair Richard S. Lindahl; Members Richard S. Lindahl (Chair); Ellen Chiniara · Claim reviewed: Oct 3, 2026
- Committee Appointment: Richard S. Lindahl: chair, Compensation Committee · Claim reviewed: Oct 3, 2026
- Committee Appointment: Ellen Chiniara: member, Compensation Committee · Claim reviewed: Oct 3, 2026
Nominating and Corporate Governance Committee
sec proxy · Source published: Date unavailable · Retrieved: Date unavailable
Supports 2 claims
- Committee Record: Nominating and Corporate Governance Committee: Chair Richard S. Lindahl; Members Richard S. Lindahl (Chair) · Claim reviewed: Oct 3, 2026
- Committee Appointment: Richard S. Lindahl: chair, Nominating and Corporate Governance Committee · Claim reviewed: Oct 3, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-03
- Board and committees
- published
- Financial statements
- not observed
- Control and shareholders
- not observed
- Compensation
- not observed
- Auditors, advisors and reporting
- not observed
- Legal
- not observed
- AI governance
- not observed